EMERYVILLE, Calif., Nov. 1 Bionovo, Inc.(Nasdaq: BNVI), a leader in the discovery and development of safe andeffective drugs in the areas of women's health and cancer, is scheduled topresent at the 9th Annual Acumen BioFin Rodman and Renshaw HealthcareConference in New York.
The presentation by Tom Chesterman, SVP and CFO of Bionovo, Inc., willtake place on November 6, 2007 at 4:45 p.m. local time at the New York PalaceHotel in New York City.
A live audio web cast and slide presentation of the event will beavailable via a link at: http://www.bionovo.com. A web cast replay will beavailable approximately one hour after the presentation ends and will continueto be accessible for 90 days after the event via Bionovo's website.
Bionovo is a pharmaceutical company focused on the discovery anddevelopment of safe and effective treatments for women's health and cancer,markets with significant unmet needs and billions in potential annual revenue.The company applies its expertise in the biology of menopause and cancer todesign new drugs derived from botanical sources which have novel mechanisms ofaction. Based on the results of early and mid-stage clinical trials, Bionovobelieves they have discovered new classes of drug candidates within their richpipeline with the potential to be leaders in their markets. Bionovo isheadquartered in Emeryville, California and is traded on the Nasdaq CapitalMarket under the symbol, "BNVI". For more information about Bionovo and itsprograms, visit http://www.bionovo.com.
SOURCE Bionovo, Inc.